PitchSend

Investor Presentaiton

INJECTION FREQUENCY AND DISEASE RECURRENCE IS SIGNIFICANTLY REDUCED WITH ILUVIEN alimera Nasdaq: ALIM % of Eyes 80 68.3 70 60 Pre ILUVIEN Post ILUVIEN 50 40 52322 40.6 34.7 30 20 10 0 0-2 3-5 Mean # of treatments per year decreased from 3.5 pre ILUVIEN to 1.7 post ILUVIEN; 51% reduction 23.3 24.8 >5 8.4 Yearly Treatment Frequency All Eyes (n=202) Data from Alimera's PALADIN Study Source: Merrill et al. Am J Ophthalmol. 2023;248:16-23. 13

View entire presentation